We are excited to launch our new orthotopic model of human glioblastoma. We use cutting-edge technology such as patient-derived xenografts (PDX) and in vivo bioluminescence
IVRS was recently appointed as industry winners or ‘’Branschvinnare’’, which is awarded to Swedish companies who have reached exceedingly positive revenue and result changes during the
We constantly work to develop clinically relevant models to provide reliable platforms for preclinical drug validation. Today, we are thrilled to announce the launch of
Introducing our pancreatic cancer segment model. At IVRS AB we are constantly working on ways to expand our service array with robust and clinically relevant methods. We
IVRS welcomes Crown Bioscience to the EUREKA project ONCO-TARGET! Two months ago, we welcomed our new collaborator within the EUROSTARS R&D and innovation project is one
With the recent expansion of our service array within NIR fluorescent imaging, PDX models and pushing state-of-the-art imaging to its limits, IVRS is ready to
Do you want to learn more about our work and how we can help you?
Visit us
